
Humacyte
Global leader in engineering regenerative medicine products to save and improve patient lives.
Market cap
$242m
Enterprise value
$219m
Share price
$1.58 HUMA
Authorizing premium user...
Global leader in engineering regenerative medicine products to save and improve patient lives.